These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24345287)

  • 1. Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy.
    Nelson DM; Hashizume R; Yoshizumi T; Blakney AK; Ma Z; Wagner WR
    Biomacromolecules; 2014 Jan; 15(1):1-11. PubMed ID: 24345287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium.
    Garbern JC; Minami E; Stayton PS; Murry CE
    Biomaterials; 2011 Mar; 32(9):2407-16. PubMed ID: 21186056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.
    Cohen JE; Purcell BP; MacArthur JW; Mu A; Shudo Y; Patel JB; Brusalis CM; Trubelja A; Fairman AS; Edwards BB; Davis MS; Hung G; Hiesinger W; Atluri P; Margulies KB; Burdick JA; Woo YJ
    Circ Heart Fail; 2014 Jul; 7(4):619-26. PubMed ID: 24902740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic fibroblast growth factor attenuates left-ventricular remodeling following surgical ventricular restoration in a rat ischemic cardiomyopathy model.
    Nagasawa A; Masumoto H; Yanagi S; Kanemitsu N; Ikeda T; Tabata Y; Minatoya K
    Gen Thorac Cardiovasc Surg; 2020 Apr; 68(4):311-318. PubMed ID: 31410725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model.
    Iwakura A; Fujita M; Kataoka K; Tambara K; Sakakibara Y; Komeda M; Tabata Y
    Heart Vessels; 2003 May; 18(2):93-9. PubMed ID: 12756606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward surgical angiogenesis using slow-released basic fibroblast growth factor.
    Sakakibara Y; Tambara K; Sakaguchi G; Lu F; Yamamoto M; Nishimura K; Tabata Y; Komeda M
    Eur J Cardiothorac Surg; 2003 Jul; 24(1):105-11; discussion 112. PubMed ID: 12853053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model.
    Shao ZQ; Takaji K; Katayama Y; Kunitomo R; Sakaguchi H; Lai ZF; Kawasuji M
    Circ J; 2006 Apr; 70(4):471-7. PubMed ID: 16565567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
    Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
    Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved therapeutic efficacy in cardiomyocyte transplantation for myocardial infarction with release system of basic fibroblast growth factor.
    Yamamoto M; Sakakibara Y; Nishimura K; Komeda M; Tabata Y
    Artif Organs; 2003 Feb; 27(2):181-4. PubMed ID: 12580776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual delivery of VEGF and ANG-1 in ischemic hearts using an injectable hydrogel.
    Rufaihah AJ; Johari NA; Vaibavi SR; Plotkin M; Di Thien DT; Kofidis T; Seliktar D
    Acta Biomater; 2017 Jan; 48():58-67. PubMed ID: 27756647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatiotemporal delivery of basic fibroblast growth factor to directly and simultaneously attenuate cardiac fibrosis and promote cardiac tissue vascularization following myocardial infarction.
    Fan Z; Xu Z; Niu H; Sui Y; Li H; Ma J; Guan J
    J Control Release; 2019 Oct; 311-312():233-244. PubMed ID: 31521744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of angiogenesis via topical delivery of basic-fibroblast growth factor from polyvinyl alcohol-dextran blend hydrogel in an ovine model of acute myocardial infarction.
    Fathi E; Nassiri SM; Atyabi N; Ahmadi SH; Imani M; Farahzadi R; Rabbani S; Akhlaghpour S; Sahebjam M; Taheri M
    J Tissue Eng Regen Med; 2013 Sep; 7(9):697-707. PubMed ID: 22674791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of basic fibroblast growth factor together with adipose-derived stem cell transplantation: improved cardiac remodeling and function in myocardial infarction.
    Wang B; Ma X; Zhao L; Zhou X; Ma Y; Sun H; Yang Y; Chen B
    Clin Exp Med; 2016 Nov; 16(4):539-550. PubMed ID: 26349680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium.
    Fujimoto KL; Ma Z; Nelson DM; Hashizume R; Guan J; Tobita K; Wagner WR
    Biomaterials; 2009 Sep; 30(26):4357-68. PubMed ID: 19487021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release of basic fibroblast growth factor using gelatin hydrogel improved left ventricular function through the alteration of collagen subtype in a rat chronic myocardial infarction model.
    Li Z; Masumoto H; Jo JI; Yamazaki K; Ikeda T; Tabata Y; Minatoya K
    Gen Thorac Cardiovasc Surg; 2018 Nov; 66(11):641-647. PubMed ID: 29982930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of brain-derived neurotrophic factor immobilized poly-lactic-co-glycolic acid membrane with human adipose-derived stem cells and basic fibroblast growth factor hydrogel on recovery of erectile dysfunction.
    Lee SH; Kim IG; Jung AR; Shrestha KR; Lee JH; Park KD; Chung BH; Kim SW; Kim KH; Lee JY
    Tissue Eng Part A; 2014 Sep; 20(17-18):2446-54. PubMed ID: 24673637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy.
    Ciuffreda MC; Malpasso G; Chokoza C; Bezuidenhout D; Goetsch KP; Mura M; Pisano F; Davies NH; Gnecchi M
    Acta Biomater; 2018 Apr; 70():71-83. PubMed ID: 29341932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
    Hughes GC; Biswas SS; Yin B; Coleman RE; DeGrado TR; Landolfo CK; Lowe JE; Annex BH; Landolfo KP
    Ann Thorac Surg; 2004 Mar; 77(3):812-8. PubMed ID: 14992878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor.
    Seif-Naraghi SB; Horn D; Schup-Magoffin PJ; Christman KL
    Acta Biomater; 2012 Oct; 8(10):3695-703. PubMed ID: 22750737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
    Matsui M; Tabata Y
    Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.